🟢 Marker Therapeutics is trading 11% up today as biotech rebound continues

Marker Therapeutics is trading 11% up today at $1.25 amid a broader biotech-led rebound and a general risk-on tone in U.S. equities.

• The move appears tied to strength in biotechnology peers following a sector-wide recovery that started late last week.
• There is no new company-specific news or earnings reports released today to account for the price action.
• The advance reflects a broader shift toward riskier assets across the U.S. equity markets.